Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "immunebiosolutions.com"

54
Business Relations
53
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 54
From Domain Role To Domain Path Aktionen
/presenting-companies-2021.html
/copy-of-projects
/membre/immune-biosolutions/
/
/breaking-silos-building-sovereignty/
/en/immune-biosolutions-to-participate-to-knowledge-for-growth-2018-in-belgium/
/en/cqdm-to-support-a-1-1-million-immune-biosolutions-research-project/
/le-cqdm-soutient-un-projet-de-11-million-de-dollars-dimmune-biosolutions/
/le-cqdm-soutient-un-projet-de-11-million-de-dollars-dimmune-biosolutions/
/immune-biosolutions-to-present-at-iccs-2018/
/en/immune-biosolutions-diex-recherche-universite-de-sherbrooke-and-keyrus-life-science-partner-up-to-fight-covid-19/
/en/neomabs-biotechnologies-a-company-dedicated-to-developing-new-immunotherapies-for-cancer-treatment-launches-in-montreal/
/en/neomabs-biotechnologies-a-company-dedicated-to-developing-new-immunotherapies-for-cancer-treatment-launches-in-montreal/
/en/neomabs-biotechnologies-a-company-dedicated-to-developing-new-immunotherapies-for-cancer-treatment-launches-in-montreal/
/immune-biosolutions-annonce-que-son-principal-produit-immunotherapeutique-ibio123-neutralise-100-des-variants-preoccupants-du-sras-cov-2-y-compris-omicron/
/recherche-et-innovation-en-sciences-de-la-vie-ottawa-et-quebec-accordent-pres-de-18-m-a-immune-biosolutions-pour-contrer-les-epidemies-virales/
/recherche-et-innovation-en-sciences-de-la-vie-ottawa-et-quebec-accordent-pres-de-18-m-a-immune-biosolutions-pour-contrer-les-epidemies-virales/
/recherche-et-innovation-en-sciences-de-la-vie-ottawa-et-quebec-accordent-pres-de-18-m-a-immune-biosolutions-pour-contrer-les-epidemies-virales/
/recherche-et-innovation-en-sciences-de-la-vie-ottawa-et-quebec-accordent-pres-de-18-m-a-immune-biosolutions-pour-contrer-les-epidemies-virales/
/lancement-de-neomabs-biotechnologies-une-entreprise-dediee-au-developpement-de-nouvelles-immunotherapies-pour-le-traitement-du-cancer/